// App-Quantinova.ai

P3-091 : PLASMA AMYLIN LEVELS ARE ASSOCIATED WITH BRAIN STRUCTURE AMONG INDIVIDUALS WITH TYPE-2 DIABETES

Researchers

Presenter

  • Timothy M. Hughes

Principal Investigators

  • Suzanne Craft

  • Michael E. Miller

  • Jeff Williamson

  • Hertzel Gerstein

  • Santica Markovina

  • Anne Murray

  • Nick Bryan

  • Lenore Launer

Medical Centers

  • National Institute on Aging (NIA/NIH), Baltimore, Maryland, United States

  • McMaster University, Hamilton, ON, Canada

  • Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

  • Berman Center for Clinical Research, Minneapolis, Minnesota, United States

  • Wake Forest University Medical Center, Winston Salem, North Carolina, United States

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

  • University of Washington, Seattle, WA, United States

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved